Kimia Farma (Persero) Tbk PT (KAEF) Stock Price & News

All values in IDR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	2.64T	2.22T	2.03T	2.67T
Cost of goods sold	1.85T	1.56T	1.29T	1.86T
Cost of revenue	1.85T	1.56T	1.29T	1.86T
Research and development expenses	5.03B	7.54B	3.20B	10.39B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	709.79B	663.87B	640.94B	620.33B
Operating expense	766.80B	877.17B	669.20B	722.39B
Total operating expenses	2.62T	2.44T	1.96T	2.59T
Operating income	23.59B	-222.99B	67.93B	84.77B
Other non operating income	-2.92B	173.66B	159.00B	-26.56B
EBT including unusual items	-94.33B	-223.75B	127.96B	-60.16B
EBT excluding unusual items	-93.48B	-260.76B	127.95B	-60.19B
Income tax expense	4.17B	-14.50B	4.32B	9.40B
Effective tax rate	-4.42%	6.48%	3.37%	-15.62%
Other operating expenses	-37.43B	-36.20B	-12.78B	-9.74B
Net income	-84.72B	-155.23B	74.45B	-64.12B
Net profit margin	-3.21%	-7.01%	3.67%	-2.40%
Earnings per share	-	-	-	-
Interest and investment income	2.65B	10.77B	2.87B	8.13B
Interest expense	-115.65B	-221.53B	-110.15B	-125.81B
Net interest expenses	-112.99B	-210.75B	-107.28B	-117.68B
Depreciation and amortization charges	89.41B	175.98B	37.85B	101.42B
EBITDA	105.34B	-86.40B	125.64B	165.62B
Gain or loss from assets sale	-	-	-	-

Finance